Safety, Tolerability and Immunogenicity of INO-4800 for COVID19 in Healthy Volunteers
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05430958 |
|
Recruitment Status :
Withdrawn
(Study was withdrawn due to sponsor decision.)
First Posted : June 24, 2022
Last Update Posted : November 17, 2022
|
Sponsor:
Inovio Pharmaceuticals
Information provided by (Responsible Party):
Inovio Pharmaceuticals
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Recruitment Status : | Withdrawn |
|---|---|
| Estimated Primary Completion Date : | March 2024 |
| Estimated Study Completion Date : | March 2024 |